Open Access Highly Accessed Open Badges Research article

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group

Alexandra Peyser, Nathaniel MacHardy, Freya Tarapore, Jacqueline MacHardy, Leslie Powell, Debbie S Gipson, Virginia Savin, Cynthia Pan, Theresa Kump, Suzanne Vento and Howard Trachtman*

BMC Nephrology 2010, 11:2  doi:10.1186/1471-2369-11-2

Article Metrics

Total accesses

Article metric FAQ


  • Last 30 days: 26 accesses
  • Last 365 days: 398 accesses
  • All time: 4547 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Open Badges